Zomedica (NYSEMKT:ZOM) just reported results for the second quarter of 2024.
- Zomedica reported earnings per share of -1 cent.
- The company reported revenue of $6.13 million.
- This was 2.06% worse than the analyst estimate for revenue of $6.26 million.
Please enter the email address associated with your account and we'll send you a magic link for a password-free sign in.
The provided email address must be associated with an account to receive a login link. If you can't find the email, please check your spam folder.
Enter your existing account details once to link them to this sign-in method.
Not Yet a Premium Subscriber?
Subscribe